News

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LRSKAN Group reports ...
CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRRelease of an ad hoc ...
The global spatial biology market is set to witness a CAGR of ~15% in the next 5 years. Increasing incidence of cancer, ...
The Global Women’s Health Market is expected to witness a growth rate of 4-5% in the next five years. Growing incidence of ...
The global infectious disease diagnostics market is set to witness a CAGR of ~7% in the next 5 years. Increasing prevalence ...
The global dental flap surgery market is expected to grow at a CAGR of ~7% during the forecast period. The rising burden of ...
FutureWise Research today announces the upcoming release of its comprehensive report, Alzheimer’s Disease Diagnostic Market – ...
Leading international experts to support clinical development of BellaSeno´s pioneering resorbable breast implantsPivotal ...
In today's highly regulated pharmaceutical and biotech environments, temperature mapping is a non-negotiable process to ...
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life ...
WINNIPEG, MB / ACCESS Newswire / August 18, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and ...
Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis  PAPZIMEOS ...